Valeo Pharma Inc
TSX:VPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cathay Real Estate Development Co Ltd
TWSE:2501
|
TW |
Valeo Pharma Inc
Inventory
Valeo Pharma Inc
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Valeo Pharma Inc
TSX:VPH
|
Inventory
CA$10.2m
|
CAGR 3-Years
127%
|
CAGR 5-Years
155%
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Inventory
$1.6B
|
CAGR 3-Years
14%
|
CAGR 5-Years
8%
|
CAGR 10-Years
3%
|
|
|
X
|
Xenon Pharmaceuticals Inc
NASDAQ:XENE
|
Inventory
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Inventory
CA$135.9m
|
CAGR 3-Years
14%
|
CAGR 5-Years
19%
|
CAGR 10-Years
57%
|
|
|
Spectral Medical Inc
TSX:EDT
|
Inventory
CA$218k
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-2%
|
|
|
Cipher Pharmaceuticals Inc
TSX:CPH
|
Inventory
$6.7m
|
CAGR 3-Years
43%
|
CAGR 5-Years
49%
|
CAGR 10-Years
20%
|
|
Valeo Pharma Inc
Glance View
Valeo Pharma, Inc. engages in the acquisitions, in-licensing or similar arrangements of patent protected, pharmaceutical products in specific therapeutic areas for the Canadian market. The company is headquartered in Kirkland, Quebec and currently employs 100 full-time employees. The company went IPO on 2019-02-20. The firm acquires or in-licenses brand and hospital specialty products for sale in Canada. The firm is focused on four therapeutic areas, which includes respiratory, oncology, specialty products and neurology. Its respiratory product is Enerzair breezhaler and Atectura breezhaler; its oncology product is Yondelis; its specialty product includes Redesca, Ametop Gel, and M-Eslon and its neurology product is Onstryv. The firm has eight marketed brands and four additional products. Its wholly owned subsidiary is VPI Pharmaceuticals Inc.(VPI).
See Also
What is Valeo Pharma Inc's Inventory?
Inventory
10.2m
CAD
Based on the financial report for Oct 31, 2023, Valeo Pharma Inc's Inventory amounts to 10.2m CAD.
What is Valeo Pharma Inc's Inventory growth rate?
Inventory CAGR 5Y
155%
Over the last year, the Inventory growth was 3%. The average annual Inventory growth rates for Valeo Pharma Inc have been 127% over the past three years , 155% over the past five years .
